Naos Yaron
SEC insider (Form 3/4/5 filer). CIK 0001742727. Sr. VP & COO at Protalix BioTherapeutics, Inc. (PLX). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 3, 2026. Located in CARMIEL.
Companies Naos Yaron has filed insider reports for
- Protalix BioTherapeutics, Inc. (PLX): Officer, Sr. VP & COO
Naos Yaron
CIK: 0001742727
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Protalix BioTherapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 3, 2026PLX
Protalix BioTherapeutics, Inc.
AwardDirectStock Option (Right to Buy)
112K shares- - Sep 3, 2026PLX
Protalix BioTherapeutics, Inc.
AwardDirectRestricted Stock Units
56K shares- - Sep 3, 2025PLX
Protalix BioTherapeutics, Inc.
AwardIndirect25K shares- - Sep 23, 2024PLX
Protalix BioTherapeutics, Inc.
AwardDirectStock Option (Right to Buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 3, 2026 | PLX Protalix BioTherapeutics, Inc. | Award Stock Option (Right to Buy) | 112,000 | - | - | Direct |
| Sep 3, 2026 | PLX Protalix BioTherapeutics, Inc. | Award Restricted Stock Units | 56,000 | - | - | Direct |
| Sep 3, 2025 | PLX Protalix BioTherapeutics, Inc. | Award | 25,000 | - | - | Indirect |
| Sep 23, 2024 | PLX Protalix BioTherapeutics, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
1-4 of 4 transactions